A Phase 1 Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Intratumoral CLN-617 (IL2/IL12 Fusion Protein) Combined with Pembrolizumab in Patients with Advanced Solid Tumors
CLN-617;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase 1 Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Intratumoral CLN-617 (IL2/IL12 Fusion Protein) Combined with Pembrolizumab in Patients with Advanced Solid Tumors ### Output: CLN-617;Pembrolizumab